ClinicalTrials.gov
ClinicalTrials.gov Menu

Arteriovenous Fistula Tissue Bank

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00836862
Recruitment Status : Completed
First Posted : February 4, 2009
Last Update Posted : February 5, 2018
Sponsor:
Information provided by (Responsible Party):
Troy Plumb, MD, University of Nebraska

Brief Summary:
This project will bank sera, DNA and vascular specimens from patients undergoing arteriovenous fistula creation and revision

Condition or disease Intervention/treatment
Kidney Failure, Chronic Other: Biologic specimens

Study Type : Observational
Actual Enrollment : 43 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Arteriovenous Fistula Tissue Bank
Actual Study Start Date : February 1, 2009
Actual Primary Completion Date : November 10, 2012
Actual Study Completion Date : September 7, 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Fistulas

Group/Cohort Intervention/treatment
Arteriovenous Fistula Other: Biologic specimens
Banking of serum, DNA and tissue




Biospecimen Retention:   Samples With DNA
Serum, Whole Blood, Tissue


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   19 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients will be eligible if they are 19 years of age or greater and have placement of an arteriovenous fistula planned witin 30 days.
Criteria

Inclusion Criteria:

  • Age 19 years of age or greater
  • Arteriovenous fistula placement for hemodialysis access scheduled within 30 days

Exclusion Criteria:

  • Incompetent to provide informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00836862


Locations
United States, Nebraska
University of Nebraska Medical Center/The Nebraska Medical Center
Omaha, Nebraska, United States, 68105
Sponsors and Collaborators
University of Nebraska

Responsible Party: Troy Plumb, MD, Principal Investigator, University of Nebraska
ClinicalTrials.gov Identifier: NCT00836862     History of Changes
Other Study ID Numbers: 482-08-EP
First Posted: February 4, 2009    Key Record Dates
Last Update Posted: February 5, 2018
Last Verified: February 2018

Keywords provided by Troy Plumb, MD, University of Nebraska:
Hemodialysis
Vascular access
Arteriovenous fistula

Additional relevant MeSH terms:
Fistula
Renal Insufficiency
Kidney Failure, Chronic
Arteriovenous Fistula
Pathological Conditions, Anatomical
Kidney Diseases
Urologic Diseases
Renal Insufficiency, Chronic
Arteriovenous Malformations
Vascular Malformations
Cardiovascular Abnormalities
Cardiovascular Diseases
Vascular Fistula
Vascular Diseases
Congenital Abnormalities